OBJECTIVE: The AcrySof toric IOL (tIOL) became available in Canada in 2006, thereby giving surgeons another option in the correction of astigmatism during cataract surgery. The purpose of this paper is to report the early experience of the acrylic AcrySof tIOL. DESIGN: Observational clinical study. PARTICIPANTS: One hundred eleven eyes, including 41 bilateral patients. METHODS: Patients were implanted with the AcrySoftIOL by 1 surgeon between April and September 2007. The eyes were followed for 6 months and pre- and postrefractive outcomes were summarized. RESULTS: Preoperatively, the mean refractive cylinder was -1.25 D compared with -0.32 D postoperative. At 6 months, 95.5% of eyes remained within 10 degrees of planned axis. Two eyes of 1 patient (1.8%) required bilateral repositioning at 2 weeks postoperative for significant rotation off axis. CONCLUSIONS: Based on our early postoperative experience, we have found the AcrySof tIOL to be successful in reducing moderate levels of astigmatism.
OBJECTIVE: The AcrySof toric IOL (tIOL) became available in Canada in 2006, thereby giving surgeons another option in the correction of astigmatism during cataract surgery. The purpose of this paper is to report the early experience of the acrylic AcrySof tIOL. DESIGN: Observational clinical study. PARTICIPANTS: One hundred eleven eyes, including 41 bilateral patients. METHODS:Patients were implanted with the AcrySoftIOL by 1 surgeon between April and September 2007. The eyes were followed for 6 months and pre- and postrefractive outcomes were summarized. RESULTS: Preoperatively, the mean refractive cylinder was -1.25 D compared with -0.32 D postoperative. At 6 months, 95.5% of eyes remained within 10 degrees of planned axis. Two eyes of 1 patient (1.8%) required bilateral repositioning at 2 weeks postoperative for significant rotation off axis. CONCLUSIONS: Based on our early postoperative experience, we have found the AcrySof tIOL to be successful in reducing moderate levels of astigmatism.
Authors: Daniel Kook; Anselm Kampik; Alois K Dexl; Nicole Zimmermann; Adrian Glasser; Martin Baumeister; Thomas Kohnen Journal: F1000 Med Rep Date: 2013-02-01